Breast cancer treatment 'being misused'

A type of breast cancer treatment which only works on certain patients is being misused by doctors, according to a new study.

The drug trastuzumab (Herceptin) should be used to combat breast cancer which shows evidence of the HER2 protein as it will otherwise be ineffective, said the authors, but this research shows that doctors are not testing for the protein enough.

Results of the study, carried out by the University of California-San Francisco Center for Translational and Policy Research on Personalized Medicine, indicate that around one in five breast cancer patients given trastuzumab have no evidence of an HER2 test.

Dr Elena Elkin, one of the study's co-authors, commented: "Our review of the literature suggests that there are important knowledge gaps regarding the real-world use of HER2 testing and trastuzumab."

A recent study showed that depression can worsen a patient's chances of surviving cancer, although it was also pointed out that patients should not feel like they have to constantly be in a happy mood to resist the illness.

Comment on this page »


Latest news

AXA PPP healthcare win at UK Customer Experience awards 2015

David Mobbs retires as CEO of Nuffield Health

King's victorious at World Transplant Games

Breast cancer treatment 'being misused'
Connect with us on:

This site compiles with the HONcode standard for trustworthy health information